Prometheus Bio

Prometheus Biosciences, Inc. (Nasdaq: RXDX) is a clinical-stage biotechnology company headquartered in San Diego, California. Founded on the belief in precision medicine, Prometheus Biosciences focuses on discovering, developing, and commercializing innovative therapeutic and companion diagnostic products. Driven by the commitment to improve treatment outcomes, Prometheus Biosciences targets immune-mediated diseases. Using a proprietary platform called Prometheus360™, they leverage cutting-edge machine learning algorithms and an extensive gastrointestinal bioinformatics database to identify promising therapeutic targets and develop corresponding candidate treatments. Their groundbreaking approach positions Prometheus Biosciences at the forefront of advancements in targeted therapies for gastrointestinal diseases. Notably, their commitment to creating a positive workplace earned them recognition as a Best Places to Work by Biospace in 2022. Those interested in connecting with Prometheus Biosciences can visit their website at prometheusbiosciences.com.